Skip to main content
FinSpry Logo
FinSpry
WGS logo
WGS
(NASDAQ)
GeneDx Holdings Corp.
$86.48-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

GeneDx Holdings (WGS) Stock Price & Financial Analysis

GeneDx Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$83.00 - $86.57
52-Week High$170.87
52-Week Low$32.21
Open$85.31
Volume426.15K
Average Volume (3M)696.63K
Market Cap2.52B
Shares Outstanding29.34M
Price to Sales (P/S)5.70
Price to Book (P/B)9.93
EV/EBITDA-67.98
Revenue (TTM)442.68M
Net Income (TTM)-77.81M
Free Cash Flow (TTM)-28.65M
EPS (TTM)$-2.63
Profit Margin-17.58%
Operating Margin-14.91%
Return on Equity (ROE)-30.62%
Debt to Equity0.40
50-Day MA$73.37
200-Day MA$84.61
52-Week Change-33.60%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About GeneDx Holdings

What is the current stock price for WGS?

As of the latest trading session, WGS stock trades at $85.87. The 52-week range is $32.21–$170.87, with a day range of $83.00–$86.57.

What is the P/E ratio for WGS?

The P/E ratio (Price-to-Earnings) for WGS is shown in the Key Statistics section. This valuation metric helps compare GeneDx Holdings Corp. to industry peers.

Does WGS pay dividends?

GeneDx Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for WGS?

Based on 2 analysts, the consensus for WGS is Buy.

What is the market cap of WGS?

GeneDx Holdings's market capitalization is $2.52B, classifying it as a mid-cap company. GeneDx Holdings operates in the Healthcare sector within the Diagnostics & Research industry.